Skip to main content
. 2017 May 15;9(5):2132–2142.

Figure 7.

Figure 7

Effects of wedelolactone on the mRNA and protein expression levels of UBE1, UBC5 and E3RS IκB in LPS-induced HRMCs. A: Relative mRNA expression of UBE1 in LPS-induced HRMCs treated with different concentrations of wedelolactone was measured by qPCR. B: Relative mRNA expression of UBC5 in LPS-induced HRMCs treated with different concentrations of wedelolactone was measured by qPCR. C: Relative mRNA expression of E3RS IκB in LPS-induced HRMCs treated with different concentrations of wedelolactone was measured by qPCR. D: Protein expression of UBE1 in LPS-induced HRMCs treated with different concentrations of wedelolactone was measured by ELISA assay. E: Protein expression of UBC5 in LPS-induced HRMCs treated with different concentrations of wedelolactone was measured by ELISA assay. F: Protein expression of E3RS IκB in LPS-induced HRMCs treated with different concentrations of wedelolactone was measured by ELISA assay. Data represent mean ± S.E.M. (n=3) *P<0.05.